The global antacids market is set to experience steady growth, with its valuation projected to rise from US$ 6,971.2 million in 2023 to US$ 11,194.8 million by 2033, according to a recent report by Future Market Insights. This represents a compound annual growth rate (CAGR) of 4.9% over the forecast period. The rising prevalence of gastrointestinal disorders, increased demand for over-the-counter (OTC) digestive products, and a shift toward self-medication are key factors driving this expansion.
Proton pump inhibitors (PPIs) continue to dominate the antacids market, holding a substantial share of approximately 25.8% as of 2022. These inhibitors have become a preferred choice for managing conditions like heartburn and gastroesophageal reflux disease (GERD), which are on the rise due to changing dietary habits, stress, and sedentary lifestyles. The convenience and accessibility of OTC antacids have further fueled consumer demand.
The growing trend of self-medication and preference for OTC digestive health products is driving market growth. As consumers seek quick, cost-effective relief from gastrointestinal discomfort, the demand for antacids in tablet, liquid, and chewable form continues to increase. Retail pharmacies, online platforms, and supermarkets are playing a pivotal role in making these products more accessible to a broad consumer base.
The antacids market is poised for sustained growth as industry players introduce new formulations and flavors to enhance consumer experience. Pharmaceutical companies are also leveraging e-commerce platforms and direct-to-consumer sales channels to expand their reach. These developments are expected to create new growth opportunities for manufacturers, retailers, and healthcare providers in the coming decade.
Full Report Revealed – https://www.futuremarketinsights.com/reports/antacids-market
Key Takeaways:
- The global antacids market is projected to grow from US$ 6,971.2 million in 2023 to US$ 11,194.8 million by 2033, with a CAGR of 4.9%.
- Proton pump inhibitors (PPIs) are leading the market, holding a 25.8% share as of 2022, driven by demand for effective solutions for GERD and heartburn.
- Rising cases of gastrointestinal disorders and the growing trend of self-medication are key factors propelling demand for OTC digestive health products.
- The introduction of innovative product formulations, combined with increased availability through retail and e-commerce channels, is driving further growth in the global antacids market.
Market Drivers
- Increase in Gastrointestinal Disorders: The rising prevalence of conditions such as heartburn and gastroesophageal reflux disease (GERD) is significantly driving the demand for antacids.
- Growing Self-Medication Trend: There is an increasing trend towards self-medication, leading to a higher demand for over-the-counter (OTC) digestive products.
- Awareness Campaigns: Initiatives aimed at raising awareness about gastrointestinal health and available treatment options are contributing to market growth.
- Accessibility of Antacids: The widespread availability of antacid products in pharmacies and retail outlets enhances consumer access and drives sales.
Competitive Landscape
The market for the production of antacids is fragmented, with several competitors. These businesses are employing strategies including collaborations, partnerships, mergers and acquisitions, and new drug releases to satisfy consumer demand and increase their client base.
Recent Development
- On 6 June 2023, The US Food and Drug Administration (FDA) gave final approval to Zydus Lifesciences to market Famotidine tablets in dosages of 20 mg and 40 mg.
- On 22 February 2023, GSK announced Haleon to be the name of its independent consumer healthcare company.
- Similarly, recent developments related to pharmaceutical companies manufacturing antacids have been tracked by the team at Future Market Insights, which are available in the full report.
Key Companies Profiled
- Johnson and Johnson
- Sanofi S.A.
- Bayer AG
- Sun Pharmaceuticals Ltd
- Zydus Lifesciences
- Abbott Laboratories
- AstraZeneca plc
- Boehringer Ingelheim International GmbH
- Dr. Reddy’s Laboratories Ltd.
- GlaxoSmithKline plc
- Pfizer Inc.
- Procter & Gamble Company
- Reckitt Benckiser Group PLC
- Takeda Pharmaceutical Company Limited.
- F. Hoffmann-La Roche Ltd
- Mylan N.V
- Hikma Pharmaceuticals PLC
- Teva Pharmaceutical Industries Ltd.
- Bristol Myers Squibb Company
- Novartis AG
- Lupin
- Cipla Inc
- Aurobindo Pharma
- Fresenius Kabi AG
- Alkem Labs.
Key Market Segments Covered in Antacids Industry Research
By Drug Class:
- Proton Pump Inhibitors
- H2 Antagonist
- Acid Neutralizers
- Pro-Motility Agents
- Anti-H.Pyrolic Drugs
- Prostaglandin Analogous
- Others
By Dosage form:
- Tablet
- Capsules
- Powder
- Liquid
- Others
By Route of Administration:
- Oral
- Injectable
By Indication:
- Gastroesophageal Reflux Disease
- Heartburn
- Peptic Ulcer
- Others
By Distribution channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
Airway Clearance Devices System Market
Mobile Operating Rooms Market
Ovulation Microscope Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube